1 completed, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Fluzone High-Dose: new trials by email Literature Review of Fluzone High-Dose trials Research Report on Fluzone High-Dose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine CIC Vaccine Co-formulated tNIV2 , SARSCoV-2 rS and Matrix-M Adjuvant, Novavax COVID-19 Vaccine, tNIV Vaccine - COVID-19 | Phase 3 | Completed | Novavax | 9320 | 2024-12-09 | 2026-06-05 |
| Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients Vaxigrip tetra, Fluzone high-dose, Aldara 5% Topical Cream - Influenza | Phase 3 | Unknown | The University of Hong Kong | 4000 | 2019-10-23 | 2021-04-28 |
Influenza, Human (2) · COVID-19 (1)
Novavax (1) · The University of Hong Kong (1)
Australia (1) · Hong Kong (1) · New Zealand (1)